Serum myeloma markers at time of bsAb reinitiation without SUD
| Myeloma serum marker . | Overall events N = 62 . |
|---|---|
| M-protein, g/dL | |
| Mean (SD) | 0.19 (0.53) |
| Median (IQR) | 0.00 (0.00-0.10) |
| Range | 0.00-2.74 |
| Free kappa light chain, mg/dL∗ | |
| Mean (SD) | 4.45 (25.83) |
| Median (IQR) | 0.08 (0.08-0.42) |
| Range | 0.08-208.23 |
| Free lambda light chain, mg/dL∗ | |
| Mean (SD) | 1.06 (4.96) |
| Median (IQR) | 0.15 (0.15-0.16) |
| Range | 0.15-38.08 |
| Myeloma serum marker . | Overall events N = 62 . |
|---|---|
| M-protein, g/dL | |
| Mean (SD) | 0.19 (0.53) |
| Median (IQR) | 0.00 (0.00-0.10) |
| Range | 0.00-2.74 |
| Free kappa light chain, mg/dL∗ | |
| Mean (SD) | 4.45 (25.83) |
| Median (IQR) | 0.08 (0.08-0.42) |
| Range | 0.08-208.23 |
| Free lambda light chain, mg/dL∗ | |
| Mean (SD) | 1.06 (4.96) |
| Median (IQR) | 0.15 (0.15-0.16) |
| Range | 0.15-38.08 |
SD, standard deviation.
Patients who had serum free light chain levels below the limit of detection were entered as the lower limit of normal in the reference range.